Spero Therapeutics Share Price Today
(NASDAQ: SPRO)

Name: Spero Therapeutics Share Price Today (NASDAQ: SPRO) - Spero Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Spero Therapeutics share price is $0.77 & ₹66.97 as on 6 Mar 2025, 2.30 'hrs' IST

$0.77

Market is closed - opens 8 PM, 06 Mar 2025

View live Spero Therapeutics share price in Dollar and Rupees. Guide to invest in Spero Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Spero Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Spero Therapeutics share price movements

Today's Low: $0.74
Today's High: $0.78
$0.77
3.88%
Downside
Day's Volatility :5.26%
Upside
1.43%
52 Weeks Low: $0.74
52 Weeks High: $1.89
$0.77
3.87%
Downside
52 Weeks Volatility :60.84%
Upside
59.26%

Spero Therapeutics (SPRO) Returns

Period	Spero Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-33.66%	2.1%	0.0%
6 Months	-42.14%	-4.1%	0.0%
1 Year	-55.26%	2.2%	0.0%
3 Years	-90.7%	11.8%	-11.6%

Spero Therapeutics (SPRO) Key Statistics

in dollars & INR

Previous Close	$0.7695
Open	$0.765
Today's High	$0.7812
Today's Low	$0.7401
Market Capitalization	$42.3M
Today's Volume	$20.1K
52 Week High	$1.89
52 Week Low	$0.7401
Revenue TTM	$106.5M
EBITDA	$-1.1M
Earnings Per Share (EPS)	$0.08
PE Ratio	9.63
Profit Margin	3.3%
Quarterly Earnings Growth YOY	0.75%
Return On Equity TTM	5.89%

How to invest in Spero Therapeutics Stock (SPRO) from India?

It is very easy for Indian residents to invest directly in Spero Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Spero Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Spero Therapeutics or SPRO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Spero Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Spero Therapeutics shares which would translate to 1.129 fractional shares of Spero Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Spero Therapeutics, in just a few clicks!

Returns in Spero Therapeutics (SPRO) for Indian investors in Rupees

The Spero Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Spero Therapeutics investment value today

Current value as on today

₹49,730

Returns

₹50,270

(-50.27%)

Returns from Spero Therapeutics Stock

₹55,233 (-55.23%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Spero Therapeutics (SPRO)

-50%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Spero Therapeutics Stock from India on INDmoney has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Spero Therapeutics

Anson Funds Management LP
7.04%
Vanguard Group Inc
3.23%
Renaissance Technologies Corp
2.03%
Alphabet Inc
1.63%
Murchinson Ltd.
1.60%
ADAR1 Capital Management LLC
1.47%

Analyst Recommendation on Spero Therapeutics

Buy

80%Buy

20%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Spero Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Spero Therapeutics Stock (SPRO)

What analysts predicted

Upside of 549.35%

Target:

$5.00

Current:

$0.77

Insights on Spero Therapeutics Stock (Ticker Symbol: SPRO)

Price Movement
In the last 3 years, SPRO stock has moved down by -91.1%
Increasing Revenue
Revenue is up for the last 3 quarters, 4.20M → 7.81M (in $), with an average increase of 26.6% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -17.86M → -17.72M (in $), with an average increase of 0.8% per quarter
SPRO vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 116.2%
SPRO vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 138.8%
Price to Sales
ForSPRO every $1 of sales, investors are willing to pay $0.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Spero Therapeutics Technicals Summary

Sell

Neutral

Buy

Spero Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Spero Therapeutics (SPRO) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Spero Therapeutics Inc	-4.16%	-42.14%	-55.26%	-90.7%	-90.95%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Spero Therapeutics Inc	9.63	9.63	0.0	-1.2	0.06	-0.01	NA	1.21
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Spero Therapeutics Inc	Buy	$42.3M	-90.95%	9.63	3.3%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Spero Therapeutics

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, an intravenous-administered antibiotic against MDR Gram-negative pathogens comprising carbapenem-resistant enterobacterales (CRE), acinetobacter baumannii, and pseudomonas aeruginosa, as well as negative bacterial infections in the hospital setting; and SPR720, a novel oral antibiotic agent for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; and Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. Spero Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Organization	Spero Therapeutics
Employees	46
CEO	Ms. Esther P. Rajavelu
Industry	Health Technology

Management People of Spero Therapeutics

Name	Title
Dr. Ankit Mahadevia M.D., MBA	Co-Founder & Director
Mr. Timothy Keutzer	Chief Operating Officer
Ms. Esther P. Rajavelu	Interim President, Interim CEO, CFO, Chief Business Officer & Treasurer
Mr. James P. Brady	Chief Human Resource Officer

Important FAQs about investing in SPRO Stock from India :

What is Spero Therapeutics share price today?

Spero Therapeutics share price today stands at $0.77, Open: $0.77 ; Previous Close: $0.77 ; High: $0.78 ; Low: $0.74 ; 52 Week High: $1.89 ; 52 Week Low: $0.74.

The stock opens at $0.77, after a previous close of $0.77. The stock reached a daily high of $0.78 and a low of $0.74, with a 52-week high of $1.89 and a 52-week low of $0.74.

Can Indians buy Spero Therapeutics shares?

Yes, Indians can invest in the Spero Therapeutics (SPRO) from India.

With INDmoney, you can buy Spero Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Spero Therapeutics at zero transaction cost.

How can I buy Spero Therapeutics shares from India?

It is very easy to buy Spero Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Spero Therapeutics (SPRO) be purchased?

Yes, you can buy fractional shares of Spero Therapeutics with INDmoney app.

What are the documents required to start investing in Spero Therapeutics stocks?

To start investing in Spero Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.